logo-education
0370 270 6000

already registered?

Please sign in with your existing account details.

need to register?

Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.

Privacy statement - Terms and conditions

Forgotten your password?

Voices raised over teacher's big pay-out

12 November 2010

A teacher who lost her voice from shouting over noise outside her classroom has been awarded a £156,000 out-of-court settlement by her employer, Hillingdon Council.

Mrs Walters’ classroom was next to a courtyard used by schoolchildren during playtime. She often had to shout and repeat herself which led to nodules forming on her vocal chords affecting her voice. Her formal grievance was rejected by her employers on the grounds that nodules were an “occupational hazard”.

The council stated that the settlement was "in the best interests of Mrs Walters, the council and taxpayers". Their decision is counter to the government’s agenda to curb compensation culture and makes it clear that employers must follow-up formal grievances with care and diligence. As councils tighten their purse strings and as more schools become their own employers of staff this case will set an unwelcome precedent.

Related opinions

Does the move into Step 4 mean the ending of Covid-19 restrictions within schools?

With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.

View blog

Advocacy in Action: Female Genital Mutilation Protection Orders (FGMPO)

The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.

View blog

Responsibilities towards students identifying as non-binary

Our top tips for supporting transgender and non-binary pupils.

View blog

Schools face scrutiny over Covid-19 vaccinations for children

On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.

View blog

Mailing list sign up

Select which mailings you would like to receive from us.

Sign up